Developing MRI biomarkers for personalized medicine
MRI Resource for Physiologic, Metabolic and Anatomic Biomarkers
This study is looking to develop new ways to use MRI scans that can help doctors personalize treatments for patients by giving them better information about their specific health conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hugo W. Moser Res Inst Kennedy Krieger NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11112346 on NIH RePORTER |
What this research studies
This research focuses on creating new noninvasive MRI biomarkers that can help tailor medical treatments to individual patients. By using advanced imaging techniques, the project aims to provide detailed information about a patient's specific disease, which can improve diagnosis, prognosis, and treatment monitoring. The goal is to enhance the development of new medical technologies and drugs by providing objective data that can guide clinical trials. Ultimately, this work seeks to advance precision medicine by ensuring that therapies are better suited to each patient's unique condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that could benefit from personalized assessment and treatment monitoring using MRI biomarkers.
Not a fit: Patients with conditions that do not involve the use of MRI or those who are not seeking personalized treatment approaches may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for patients based on their specific disease characteristics.
How similar studies have performed: Other research has shown promise in using imaging biomarkers for precision medicine, indicating that this approach has potential for success.
Where this research is happening
Baltimore, United States
- Hugo W. Moser Res Inst Kennedy Krieger — Baltimore, United States (Active)
Researchers
- Principal investigator: Van Zijl, Peter Cm — Hugo W. Moser Res Inst Kennedy Krieger
- Study coordinator: Van Zijl, Peter Cm
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.